User Tools

Site Tools


meningiomas

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
meningiomas [2026/07/17 07:03] – [Risk factors] gary1meningiomas [2026/07/17 07:03] (current) – [Risk factors] gary1
Line 24: Line 24:
     * neurofibromatosis type 2 - 50% develop one or more meningiomas     * neurofibromatosis type 2 - 50% develop one or more meningiomas
     * ionizing radiation - frequent dental xrays (esp. older higher dose ones);     * ionizing radiation - frequent dental xrays (esp. older higher dose ones);
-    * long-acting injectable contraceptive depot medroxyprogesterone acetate (Depo-Provera)+    * long-acting injectable [[contraception]] depot medroxyprogesterone acetate (Depo-Provera)
       *class action against manufacturer Pfizer on claims it may increase the risk of meningiomas - studies suggest it's use increases risk of meningioma by 1.5-5.5 fold, and risk appears to be greatest in those starting over age 31 yr or using it for more than 4 years (([[https://pubmed.ncbi.nlm.nih.gov/42166750/|2026: Epidemiological and clinical data link depot medroxyprogesterone acetate to meningioma ]]))       *class action against manufacturer Pfizer on claims it may increase the risk of meningiomas - studies suggest it's use increases risk of meningioma by 1.5-5.5 fold, and risk appears to be greatest in those starting over age 31 yr or using it for more than 4 years (([[https://pubmed.ncbi.nlm.nih.gov/42166750/|2026: Epidemiological and clinical data link depot medroxyprogesterone acetate to meningioma ]]))
     * high doses of cyproterone acetate     * high doses of cyproterone acetate
meningiomas.txt · Last modified: 2026/07/17 07:03 by gary1

Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki